Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

UK deal over inclisiran.

Byrne P, Cullinan J, Mintzes B, Smith SM.

BMJ. 2020 Feb 18;368:m579. doi: 10.1136/bmj.m579. No abstract available.

PMID:
32071100
2.

Media coverage of drug regulatory agencies' safety advisories: a case study of citalopram and denosumab.

Fabbri A, O'Keeffe M, Moynihan R, Møllebaek M, Mohammad A, Bhasale A, Puil L, Mintzes B.

Br J Clin Pharmacol. 2020 Feb 17. doi: 10.1111/bcp.14255. [Epub ahead of print]

PMID:
32067255
3.

The "Nuts and Bolts" of Opioid Marketing: Promotional Messages to Family Doctors in Sacramento, Vancouver, Montreal, and Toulouse.

Mintzes B, Lexchin J.

J Gen Intern Med. 2020 Feb 10. doi: 10.1007/s11606-019-05584-5. [Epub ahead of print] No abstract available.

PMID:
32043257
4.

Flawed evidence underpins approval of new cancer drugs.

Mintzes B, Vitry A.

BMJ. 2019 Sep 18;366:l5399. doi: 10.1136/bmj.l5399. No abstract available.

PMID:
32027600
5.

Industry funding of patient and health consumer organisations: systematic review with meta-analysis.

Fabbri A, Parker L, Colombo C, Mosconi P, Barbara G, Frattaruolo MP, Lau E, Kroeger CM, Lunny C, Salzwedel DM, Mintzes B.

BMJ. 2020 Jan 22;368:l6925. doi: 10.1136/bmj.l6925.

6.

Impact and use of reviews and 'overviews of reviews' to inform clinical practice guideline recommendations: protocol for a methods study.

Lunny C, Ramasubbu C, Gerrish S, Liu T, Salzwedel DM, Puil L, Mintzes B, Wright JJ.

BMJ Open. 2020 Jan 20;10(1):e031442. doi: 10.1136/bmjopen-2019-031442.

7.

"Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.

Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L.

BMJ. 2019 Dec 12;367:l6694. doi: 10.1136/bmj.l6694.

PMID:
31831471
8.

Pathways to independence: towards producing and using trustworthy evidence.

Moynihan R, Bero L, Hill S, Johansson M, Lexchin J, Macdonald H, Mintzes B, Pearson C, Rodwin MA, Stavdal A, Stegenga J, Thombs BD, Thornton H, Vandvik PO, Wieseler B, Godlee F.

BMJ. 2019 Dec 3;367:l6576. doi: 10.1136/bmj.l6576. No abstract available.

PMID:
31796508
9.

Missing data reporting in clinical pharmacy research.

Narayan SW, Yu Ho K, Penm J, Mintzes B, Mirzaei A, Schneider C, Patanwala AE.

Am J Health Syst Pharm. 2019 Dec 2;76(24):2048-2052. doi: 10.1093/ajhp/zxz245.

PMID:
31789352
10.

Inadequate conflict of interest policies at most French teaching hospitals: A survey and website analysis.

Guy-Coichard C, Perraud G, Chailleu A, Gaillac V, Scheffer P, Mintzes B.

PLoS One. 2019 Nov 1;14(11):e0224193. doi: 10.1371/journal.pone.0224193. eCollection 2019.

11.

National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism.

Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, De Fiore L, Deyo RA, Elshaug A, Farquhar C, Fatovich DM, Fingerman E, Gérvas J, Gøtzsche PC, Gracia R, Heath I, Himmelstein DU, Hoffman JR, Järvinen T, Jureidini J, Kotaska A, Kuehlein T, Lenzer J, Levenstein S, Lexchin J, Mintzes B, Naudet F, Niquette M, Orellana Navarrete LP, Pearson CA, Rail G, Roberts R, Shah N, Sharav V, Siwek J, Topolski S, Tsai AC.

Obstet Gynecol. 2019 Nov;134(5):1115-1117. doi: 10.1097/AOG.0000000000003540. No abstract available.

PMID:
31651818
12.

Validation of five search filters for retrieval of clinical practice guidelines produced low precision.

Lunny C, Salzwedel DM, Liu T, Ramasubbu C, Gerrish S, Puil L, Mintzes B, Wright JM.

J Clin Epidemiol. 2020 Jan;117:109-116. doi: 10.1016/j.jclinepi.2019.09.022. Epub 2019 Oct 11.

13.

Are Safety Warnings for Commonly-Used Sleeping Pills Reaching Those who Need them Most?

Mintzes B.

J Law Med Ethics. 2019 Sep;47(3):442-444. doi: 10.1177/1073110519876177. No abstract available.

PMID:
31560632
14.

Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media.

Cosgrove L, Cristea IA, Shaughnessy AF, Mintzes B, Naudet F.

BMJ Evid Based Med. 2019 Dec;24(6):231-238. doi: 10.1136/bmjebm-2019-111204. Epub 2019 Jul 18.

PMID:
31320322
15.

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom.

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B.

JAMA Intern Med. 2019 Jul 1;179(7):982-984. doi: 10.1001/jamainternmed.2019.0294. No abstract available.

PMID:
31033999
16.

Secret safety warnings on medicines: A case study of information access requests.

Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J.

Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):551-555. doi: 10.1002/pds.4762. Epub 2019 Mar 6.

PMID:
30840349
17.

Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.

Fabbri A, Swandari S, Lau E, Vitry A, Mintzes B.

Int J Health Serv. 2019 Apr;49(2):273-293. doi: 10.1177/0020731418823376. Epub 2019 Jan 15.

PMID:
30646806
18.

The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures.

Bero L, Chartres N, Diong J, Fabbri A, Ghersi D, Lam J, Lau A, McDonald S, Mintzes B, Sutton P, Turton JL, Woodruff TJ.

Syst Rev. 2018 Dec 21;7(1):242. doi: 10.1186/s13643-018-0915-2.

19.

Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards.

Leonardo Alves T, Poplavska E, Mezinska S, Salmane-Kulikovska I, Andersone L, Mantel-Teeuwisse AK, Mintzes B.

BMC Public Health. 2018 Nov 28;18(1):1322. doi: 10.1186/s12889-018-6202-2.

20.

Industry sponsorship and research outcome: systematic review with meta-analysis.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L.

Intensive Care Med. 2018 Oct;44(10):1603-1612. doi: 10.1007/s00134-018-5293-7. Epub 2018 Aug 21.

PMID:
30132025
21.

How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.

Lau E, Fabbri A, Mintzes B.

Aust Health Rev. 2018 Jul 19. doi: 10.1071/AH17288. [Epub ahead of print]

PMID:
30021681
22.

Mental Health Messages in Prominent Mental Health Apps.

Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, Grundy Q.

Ann Fam Med. 2018 Jul;16(4):338-342. doi: 10.1370/afm.2260.

23.

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.

Fabbri A, Santos A, Mezinska S, Mulinari S, Mintzes B.

Int J Health Policy Manag. 2018 Jun 1;7(6):504-509. doi: 10.15171/ijhpm.2018.20.

24.

Medicines Information and the Regulation of the Promotion of Pharmaceuticals.

Leonardo Alves T, Lexchin J, Mintzes B.

Sci Eng Ethics. 2019 Aug;25(4):1167-1192. doi: 10.1007/s11948-018-0041-5. Epub 2018 May 2.

25.

The rise of ambiguous competing interest declarations.

Mintzes B, Grundy Q.

BMJ. 2018 Apr 10;361:k1464. doi: 10.1136/bmj.k1464. No abstract available.

PMID:
29636334
26.

The marketing of testosterone treatments for age-related low testosterone or 'Low T'.

Mintzes B.

Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):224-230. doi: 10.1097/MED.0000000000000412. Review.

PMID:
29570470
27.

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L.

BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027.

28.

Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care.

Reynolds E, Guénette L, Lexchin J, Cassels A, Wilkes MS, Durrieu G, Beaulieu MD, Mintzes B.

Health Policy. 2018 Mar;122(3):250-255. doi: 10.1016/j.healthpol.2018.01.010. Epub 2018 Feb 1.

PMID:
29395543
29.

Mental health care and suicide in pregnancy and postpartum.

Mintzes B.

CMAJ. 2017 Dec 4;189(48):E1498. doi: 10.1503/cmaj.733429. No abstract available.

30.

A health app developer's guide to law and policy: a multi-sector policy analysis.

Parker L, Karliychuk T, Gillies D, Mintzes B, Raven M, Grundy Q.

BMC Med Inform Decis Mak. 2017 Oct 2;17(1):141. doi: 10.1186/s12911-017-0535-0.

31.

Response to "use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter".

Smolina K, Morgan S, Mintzes B, Hanley G, Oberlander T.

Pharmacoepidemiol Drug Saf. 2017 Jul;26(7):865-866. doi: 10.1002/pds.4229. No abstract available.

PMID:
28671317
32.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

33.

Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?

Habibi R, Lexchin J, Mintzes B, Holbrook A.

Br J Clin Pharmacol. 2017 Nov;83(11):2549-2556. doi: 10.1111/bcp.13360. Epub 2017 Aug 19.

34.

Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States.

Habibi R, Guénette L, Lexchin J, Reynolds E, Wiktorowicz M, Mintzes B.

J Law Med Ethics. 2016 Dec;44(4):602-613. doi: 10.1177/1073110516684803.

PMID:
28661249
35.

Industry sponsorship and research outcome.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L.

Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033. doi: 10.1002/14651858.MR000033.pub3. Review.

PMID:
28207928
36.

Conflict of Interest Policies at French Medical Schools: Starting from the Bottom.

Scheffer P, Guy-Coichard C, Outh-Gauer D, Calet-Froissart Z, Boursier M, Mintzes B, Borde JS.

PLoS One. 2017 Jan 9;12(1):e0168258. doi: 10.1371/journal.pone.0168258. eCollection 2017.

37.

The Inclusion of Nurses in Pharmaceutical Industry-Sponsored Events: Guess Who Is Also Coming to Dinner?

Grundy Q, Fabbri A, Mintzes B, Swandari S, Bero L.

JAMA Intern Med. 2016 Nov 1;176(11):1718-1720. doi: 10.1001/jamainternmed.2016.5276. No abstract available.

PMID:
27617386
38.

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Morgan SG, Gagnon MA, Mintzes B, Lexchin J.

Healthc Policy. 2016 Aug;12(1):18-36.

39.

In Reply.

Hanley GE, Mintzes B.

Obstet Gynecol. 2016 Aug;128(2):406. doi: 10.1097/AOG.0000000000001542. No abstract available.

PMID:
27454714
40.

The association between domperidone and ventricular arrhythmia in the postpartum period.

Smolina K, Mintzes B, Hanley GE, Oberlander TF, Morgan SG.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1210-1214. doi: 10.1002/pds.4035. Epub 2016 Jun 14.

PMID:
27296864
41.

Postpartum domperidone use in British Columbia: a retrospective cohort study.

Smolina K, Morgan SG, Hanley GE, Oberlander TF, Mintzes B.

CMAJ Open. 2016 Jan 12;4(1):E13-9. doi: 10.9778/cmajo.20150067. eCollection 2016 Jan-Mar.

43.

Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults.

Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, Mintzes B.

Age Ageing. 2016 Jul;45(4):535-42. doi: 10.1093/ageing/afw074. Epub 2016 May 5.

44.

Access to new cancer medicines in Australia: dispelling the myths and informing a public debate.

Vitry A, Mintzes B, Lipworth W.

J Pharm Policy Pract. 2016 Apr 7;9:13. doi: 10.1186/s40545-016-0062-x. eCollection 2016.

45.

Under the Influence: The Interplay among Industry, Publishing, and Drug Regulation.

Cosgrove L, Vannoy S, Mintzes B, Shaughnessy AF.

Account Res. 2016;23(5):257-79. doi: 10.1080/08989621.2016.1153971.

PMID:
26890488
46.

Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy.

Hanley GE, Smolina K, Mintzes B, Oberlander TF, Morgan SG.

Obstet Gynecol. 2016 Mar;127(3):553-61. doi: 10.1097/AOG.0000000000001200.

PMID:
26855096
47.

Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect.

Mintzes B, Lexchin J, Quintano AS.

Br Med Bull. 2015;116:43-53. doi: 10.1093/bmb/ldv042. Epub 2015 Oct 21. Review.

PMID:
26493102
48.

Authors' reply to Lee and colleagues.

Järvinen T, Michaëlsson K, Jokihaara J, Collins GS, Perry TL, Mintzes B, Musini V, Erviti J, Gorricho J, Wright JM, Sievänen H.

BMJ. 2015 Jul 14;351:h3737. doi: 10.1136/bmj.h3737. No abstract available.

PMID:
26174986
49.

When drugs don't make it to market.

Mintzes B.

BMJ. 2015 Jun 9;350:h2852. doi: 10.1136/bmj.h2852. No abstract available.

PMID:
26060187
50.

Overdiagnosis of bone fragility in the quest to prevent hip fracture.

Järvinen TL, Michaëlsson K, Jokihaara J, Collins GS, Perry TL, Mintzes B, Musini V, Erviti J, Gorricho J, Wright JM, Sievänen H.

BMJ. 2015 May 26;350:h2088. doi: 10.1136/bmj.h2088. No abstract available.

PMID:
26013536

Supplemental Content

Loading ...
Support Center